Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Alaiwi SA"'
Autor:
Alaiwi SA; Section of Cardiovascular Medicine, Yale University School of Medicine., Rosenfeld LE; Section of Cardiovascular Medicine, Yale University School of Medicine. Electronic address: lynda.rosenfeld@yale.edu.
Publikováno v:
The American journal of cardiology [Am J Cardiol] 2024 Nov 21. Date of Electronic Publication: 2024 Nov 21.
Autor:
German B; Department of Surgery, Center for Prostate Disease Research, Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland.; Walter Reed National Military Medical Center, Bethesda, Maryland.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Alaiwi SA; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut., Ho KL; Department of Surgery, Center for Prostate Disease Research, Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland.; Walter Reed National Military Medical Center, Bethesda, Maryland.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland., Nanda JS; Department of Urology, Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California., Fonseca MA; Department of Obstetrics and Gynecology and the Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Burkhart DL; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Sheahan AV; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Bergom HE; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, Minnesota., Morel KL; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Hwang JH; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, Minnesota., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Lawrenson K; Department of Obstetrics and Gynecology and the Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.; Center for Bioinformatics and Functional Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Ellis L; Department of Surgery, Center for Prostate Disease Research, Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland.; Walter Reed National Military Medical Center, Bethesda, Maryland.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Sep 01; Vol. 4 (9), pp. 2295-2307.
Autor:
Alaiwi SA; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA., Desai N; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA., Ahmad T; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA. Electronic address: tariq.ahmad@yale.edu.
Publikováno v:
JACC. Heart failure [JACC Heart Fail] 2024 Apr; Vol. 12 (4), pp. 693-694.
Autor:
Alaiwi SA; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Colna M; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Clark KAA; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA. Electronic address: katherine.clark@yale.edu.
Publikováno v:
JACC. Heart failure [JACC Heart Fail] 2024 Apr; Vol. 12 (4), pp. 675-677. Date of Electronic Publication: 2024 Jan 10.
Autor:
Spisak S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Tisza V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA, 02215, USA.; Institute of Enzymology, Research Centre for Natural Sciences, Budapest, 1117, Hungary., Nuzzo PV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Lgo R. Benzi 10, 16132, Italy., Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Pataki B; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary., Ribli D; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary., Sztupinszki Z; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA, 02215, USA., Bell C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Rohanizadegan M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Stillman DR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Alaiwi SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Bartels AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Papp M; Institute of Enzymology, Research Centre for Natural Sciences, Budapest, 1117, Hungary.; Centre for Bioinformatics, University of Veterinary Medicine, Istvan str. 2, Budapest, 1078, Hungary., Shetty A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Division of Genetics, Brigham & Women's Hospital, Boston, MA, USA., Abbasi F; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Lin X; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Lawrenson K; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Center for Bioinformatics and Functional Genomics, Department of Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Gayther SA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Center for Bioinformatics and Functional Genomics, Department of Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Pomerantz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Baca S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA., Solymosi N; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary., Csabai I; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary., Szallasi Z; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA, 02215, USA.; Department of Bioinformatics, Forensic and Insurance Medicine Semmelweis University, Budapest, Hungary.; Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.; National Korányi Institute of Pulmonology, Budapest, 1112, Hungary., Gusev A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Division of Genetics, Brigham & Women's Hospital, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. matthew_freedman@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. matthew_freedman@dfci.harvard.edu.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA. matthew_freedman@dfci.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2023 Oct 19; Vol. 14 (1), pp. 6623. Date of Electronic Publication: 2023 Oct 19.
Autor:
Gjuka D; Department of Chemical Engineering, University of Texas, Austin, TX, USA., Adib E; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Lank Genitourinary Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Garrison K; Department of Chemical Engineering, University of Texas, Austin, TX, USA., Chen J; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang Y; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li W; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Boutz D; Department of Molecular Biosciences, University of Texas, Austin, TX, USA., Lamb C; Department of Chemical Engineering, University of Texas, Austin, TX, USA; Department of Molecular Biosciences, University of Texas, Austin, TX, USA., Tanno Y; Department of Chemical Engineering, University of Texas, Austin, TX, USA., Nassar A; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., El Zarif T; Lank Genitourinary Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kale N; Worcester Polytechnic Institute, Worcester, MA, USA., Rakaee M; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Mouhieddine TH; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY, USA., Alaiwi SA; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Lank Genitourinary Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gusev A; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Rogers T; Children's Medical Center Research Institute, University of Texas Southwestern, Dallas, TX, USA., Gao J; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Georgiou G; Department of Chemical Engineering, University of Texas, Austin, TX, USA; Department of Molecular Biosciences, University of Texas, Austin, TX, USA; Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX, USA; Department of Oncology, University of Texas Dell Medical School, LiveSTRONG Cancer Institutes, Austin, TX, USA., Kwiatkowski DJ; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: dk@rics.bwh.harvard.edu., Stone E; Department of Molecular Biosciences, University of Texas, Austin, TX, USA; Department of Oncology, University of Texas Dell Medical School, LiveSTRONG Cancer Institutes, Austin, TX, USA. Electronic address: stonesci@utexas.edu.
Publikováno v:
Cancer cell [Cancer Cell] 2023 Oct 09; Vol. 41 (10), pp. 1774-1787.e9. Date of Electronic Publication: 2023 Sep 28.
Autor:
Spisak S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Tisza V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA, 02215, USA.; Institute of Enzymology, Research Centre for Natural Sciences, Budapest, 1117, Hungary., Nuzzo PV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Lgo R. Benzi 10, 16132, Italy., Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Pataki B; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary., Ribli D; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary., Sztupinszki Z; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA, 02215, USA., Bell C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Rohanizadegan M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Stillman DR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Alaiwi SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Bartels AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Papp M; Institute of Enzymology, Research Centre for Natural Sciences, Budapest, 1117, Hungary.; Centre for Bioinformatics, University of Veterinary Medicine, Istvan str. 2, Budapest, 1078, Hungary., Shetty A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Division of Genetics, Brigham & Women's Hospital, Boston, MA, USA., Abbasi F; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Lin X; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Lawrenson K; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Center for Bioinformatics and Functional Genomics, Department of Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Gayther SA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.; Center for Bioinformatics and Functional Genomics, Department of Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Pomerantz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Baca S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA., Solymosi N; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary., Csabai I; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest, 1117, Hungary., Szallasi Z; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA, 02215, USA.; Department of Bioinformatics, Forensic and Insurance Medicine Semmelweis University, Budapest, Hungary.; Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.; National Korányi Institute of Pulmonology, Budapest, 1112, Hungary., Gusev A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Division of Genetics, Brigham & Women's Hospital, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. matthew_freedman@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. matthew_freedman@dfci.harvard.edu.; The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA. matthew_freedman@dfci.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2023 Aug 23; Vol. 14 (1), pp. 5118. Date of Electronic Publication: 2023 Aug 23.
Autor:
Groha S; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Alaiwi SA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Xu W; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Naranbhai V; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Nassar AH; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., El Zarif T; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Saliby RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Wan G; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA., Rajeh A; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA., Adib E; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Nuzzo PV; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Genoa, Italy., Schmidt AL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Alessi JV; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Genoa, Italy., Braun DA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Shukla SA; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA., Keenan TE; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA., Van Allen E; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA, USA., Awad MM; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Genoa, Italy., Manos M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Rahma O; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Zubiri L; Massachusetts General Hospital, Boston, MA, USA., Villani AC; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Immunology and Inflammatory Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Fairfax B; Department of Oncology, University of Oxford, Oxford, UK., Hammer C; Genentech, South San Francisco, CA, USA., Khan Z; Genentech, South San Francisco, CA, USA., Reynolds K; Harvard Medical School, Boston, MA, USA.; Division of Medical Oncology, Bartlett, Massachusetts General Hospital, Boston, MA, USA., Semenov Y; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA., Schrag D; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kehl KL; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Freedman ML; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Choueiri TK; Harvard Medical School, Boston, MA, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Gusev A; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. alexander_gusev@dfci.harvard.edu.; Broad Institute of Harvard & MIT, Cambridge, MA, USA. alexander_gusev@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. alexander_gusev@dfci.harvard.edu.; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA. alexander_gusev@dfci.harvard.edu.
Publikováno v:
Nature medicine [Nat Med] 2022 Dec; Vol. 28 (12), pp. 2584-2591. Date of Electronic Publication: 2022 Dec 16.
Autor:
Bakouny Z; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Labaki C; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Bhalla S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA., Schmidt AL; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Steinharter JA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Cocco J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA., Tremblay DA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA., Awad MM; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Kessler A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA., Haddad RI; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Evans M; Department of Medicine, Icahn School of Medicine at Mount Sinai Hospital, New York, USA., Busser F; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Wotman M; Department of Medicine, Icahn School of Medicine at Mount Sinai Hospital, New York, USA., Curran CR; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Zimmerman BS; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA., Bouchard G; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Jun T; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA., Nuzzo PV; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Qin Q; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA., Hirsch L; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Feld J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA., Kelleher KM; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Seidman D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA., Huang H; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA., Anderson-Keightly HM; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA., El Zarif T; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Alaiwi SA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Champagne C; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Rosenbloom TD; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA., Stewart PS; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA., Johnson BE; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Trinh Q; Division of Urological Surgery, Brigham and Women's Hospital, Boston, USA., Tolaney SM; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Galsky MD; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA., Choueiri TK; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA. Electronic address: toni_choueiri@dfci.harvard.edu., Doroshow DB; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, USA. Electronic address: deborah.doroshow@mssm.edu.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2022 Aug; Vol. 33 (8), pp. 836-844. Date of Electronic Publication: 2022 Jun 14.
Autor:
Tang S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Sethunath V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Metaferia NY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Nogueira MF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Gallant DS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Garner ER; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Lairson LA; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Penney CM; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Li J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Gelbard MK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Alaiwi SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Hwang JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Strathdee CA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., AbuHammad S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Zhang X; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA., Doench JG; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Medical School, Boston, MA 02215, USA., Takeda DY; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA., Choi PS; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Pathology & Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: peter.choi@pennmedicine.upenn.edu., Viswanathan SR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Medical School, Boston, MA 02215, USA. Electronic address: srinivas.viswanathan@dfci.harvard.edu.
Publikováno v:
Cell reports [Cell Rep] 2022 Feb 22; Vol. 38 (8), pp. 110417.